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ABSTRACT
Background The relationship between physical activity,
disease severity, health status and prognosis in patients
with COPD has not been systematically assessed. Our
aim was to identify and summarise studies assessing
associations between physical activity and its
determinants and/or outcomes in patients with COPD
and to develop a conceptual model for physical activity
in COPD.
Methods We conducted a systematic search of four
databases (Medline, Embase, CINAHL and Psychinfo)
prior to November 2012. Teams of two reviewers
independently selected articles, extracted data and used
the Grading of Recommendations Assessment,
Development, and Evaluation (GRADE) to assess quality
of evidence.
Results 86 studies were included: 59 were focused on
determinants, 23 on outcomes and 4 on both.
Hyperinﬂation, exercise capacity, dyspnoea, previous
exacerbations, gas exchange, systemic inﬂammation,
quality of life and self-efﬁcacy were consistently related
to physical activity, but often based on cross-sectional
studies and low-quality evidence. Results from studies of
pharmacological and non-pharmacological treatments
were inconsistent and the quality of evidence was low to
very low. As outcomes, COPD exacerbations and
mortality were consistently associated with low levels of
physical activity based on moderate quality evidence.
Physical activity was associated with other outcomes
such as dyspnoea, health-related quality of life, exercise
capacity and FEV1 but based on cross-sectional studies
and low to very low quality evidence.
Conclusions Physical activity level in COPD is
consistently associated with mortality and exacerbations,
but there is poor evidence about determinants of
physical activity, including the impact of treatment.
INTRODUCTION
A substantial amount of research about physical
activity in patients with COPD has been published
recently, prompted by studies showing that low
levels of physical activity are associated with poor
prognosis in COPD1 2 and by observations that
patients with COPD are substantially less physically
active than healthy subjects of the same age and
sex.3 4 As a result there is the general notion that
physical activity is important for patients with
COPD.
Knowledge about the determinants and outcomes
of physical activity in patients with COPD is needed
to design interventions, to guide further research
including randomised clinical trials and to improve
the management of patients with COPD. It is cur-
rently unclear what the determinants and outcomes
of different levels of physical activity are and to
what extent current pharmacological and non-
pharmacological treatments may modify physical
activity levels. A determinant is deﬁned as any factor
that brings about change in a health condition or
other deﬁned characteristics, such as physical activ-
ity levels.5 Determinants can be modiﬁable (eg,
dyspnea) or non-modiﬁable (eg, age), and can also
include interventions that may modify levels of
physical activity, such as pulmonary rehabilitation or
behavioural support. In the same way, an outcome is
deﬁned as all the possible results that may stem from
an exposure, such as low levels of physical activity.5
Occasionally the same variable may be a determin-
ant or an outcome of physical activity (eg, lung func-
tion or health related quality of life).
A recent expert review presented an interesting
theoretical framework describing the role and con-
sequences of physical inactivity in patients with
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Key messages
What is the key question?
▸ Despite the increasing research on physical
activity and COPD, it is unclear which are the
determinants and outcomes of physical activity
in patients with COPD.
What is the bottom line?
▸ Physical activity level in COPD is consistently
associated with mortality and exacerbations,
but this is in contrast to the poor evidence
about determinants of physical activity,
including current COPD treatments.
Why read on?
▸ This is a systematic review that will help
clinicians to interpret the currently very
heterogeneous literature on the topic and
investigators to identify which research needs
to be prioritised.
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COPD,6 but was not based on a systematic and thus a complete
review of the available literature of the determinants and out-
comes of physical activity. Therefore, our aim was to identify
and summarise studies assessing associations between physical
activity and its determinants and/or outcomes in patients with
COPD.
METHODS
Data sources and searches
This study was part of the European Commission funded
PROactive project (http://www.proactivecopd.com), which aims to
develop and validate patient-reported outcome (PRO) instruments
that capture the dimensions of physical activity in daily life relevant
to patients with COPD. We utilised standard systematic review
methodology following the handbooks of the Centre for Reviews
and Dissemination7 and the Cochrane Collaboration.8 The manu-
script follows the PRISMA9 statement for reporting of systematic
reviews and meta-analyses. All methods were speciﬁed in advance,
documented in a protocol (see online supplement 1), and approved
by the PROactive consortium. Details of the performed searches
are provided in online supplement 2.
The bibliographic details of all retrieved articles were stored
in a RefWorks-COS ﬁle. We removed duplicate records resulting
from the various database searches. The source of identiﬁed arti-
cles (database, hand search, researcher contacts) was recorded in
a ‘user deﬁned ﬁeld’ of the RefWorks-COS ﬁle. An additional
‘user deﬁned ﬁeld’ was assigned to individual reviewers where
they recorded their decision for inclusion and exclusion.
Study selection
Two reviewers independently assessed the title and abstract of
every citation retrieved by the database searches (form available
in online supplement 3). The decisions of the reviewers (order
full text or reject citation) were recorded in the RefWorks-COS
ﬁle and compared. We ordered all articles that were deemed
potentially eligible by at least one member of the consortium.
Two independent reviewers evaluated the retrieved full texts and
made a decision on inclusion or exclusion according to the prede-
ﬁned selection criteria (form available in online supplement 4).
Any disagreements in any phase were resolved by consensus,
with close attention paid to the previously deﬁned inclusion/
exclusion criteria. In the case of persistent disagreement, a third
member adjudicated. All studies that did not fulﬁl the predeﬁned
criteria were excluded and their bibliographic details were listed
with the speciﬁc reason for exclusion.
We included studies if they fulﬁlled the following criteria:
1. Studies in which determinants and outcomes of physical
activity, explicitly or implicitly deﬁned as ‘any bodily move-
ment produced by skeletal muscles that results in energy
expenditure’10 were assessed.
2. Study design: longitudinal observational studies (prospective
and retrospective); randomised and non-randomised trials:
both arms (intervention+control) if the outcome was phys-
ical activity, or only the control arm when used in an analysis
similar to a longitudinal observational study; and cross-
sectional and case–control observational studies if they
included associations with other variables.
3. Population: patients with COPD deﬁned by spirometry (any
deﬁnition as long as it was based on spirometry).
4. Causal direction (directionality): with directionality we refer
to the establishment of a temporal relationship between a
determinant (must exist before levels of physical activity
change) and physical activity. We included studies in which
the design of the study allowed an assumption of causal
direction in associations between ‘determinant and physical
activity’ or ‘physical activity and outcome’, that is, longitu-
dinal studies and clinical trials, and studies in which the
design could not address causality, that is, cross-sectional
studies, but the authors clearly stated in the introduction or
in the methods which was the hypothesised direction.
5. No language or date restrictions were imposed.
Data extraction and quality assessment
A Microsoft Ofﬁce Access form was developed and used for
data extraction. Two reviewers performed a pilot test of 10 ran-
domly selected articles; the form was then reﬁned prior to the
ﬁnal extraction process. The ﬁnal version of the data extraction
form was used by ﬁve independent reviewers to screen the full
text of the included studies. Any disagreements were resolved
by consensus, with close attention paid to the data extraction
criteria (more details in online supplement 5).
We assessed the quality of the evidence for each association of
physical activity with its determinants and outcomes following
the Grading of Recommendations Assessment, Development
and Evaluation (GRADE) approach11 12 (more details in online
supplement 5).
Data synthesis and analysis
The results of the data extraction were summarised in structured
tables, one for determinants and one for outcomes. We did not
perform meta-analyses because we deemed the studies to be too
different to summarise their results statistically. However, we
illustrated the individual effect of each study graphically for
those determinants and/or outcomes that showed consistent
results (eg, all showing results in the same direction) and when
the quality of evidence was at least moderate. We developed a
conceptual model based on the determinants and outcomes
included in the assessment and on the quality of evidence, high-
lighting the directionality, the consistency and the conﬁdence
rating.
RESULTS
Summary of studies
Figure 1 shows the ﬂow diagram of the identiﬁcation of the
studies, from 3687 references to 86 articles that were ﬁnally
included. Online supplementary table S1 shows the reasons for
exclusion. From 86 studies included, 59 assessed only determi-
nants of physical activity in COPD, 23 only outcomes and 4
both. Table 1 shows information on reference details, study
design and number of subjects included in each study (S1–S86
on references section of online supplement). Regarding the
study design, 36 were cross-sectional, 4 case–control, 16 longi-
tudinal, 12 randomised controlled trials and 18 non-randomised
and/or non-controlled studies. Online supplementary table S2
shows detailed information on patients’ characteristics and
instruments for measuring physical activity of the 86 studies
included. Almost half of the studies (n=38) measured physical
activity using only a direct method (accelerometer and/or ped-
ometer), 43 used only an indirect method (validated or non-
validated questionnaire), and 5 used both direct and indirect
methods.
A large body of research focused on typical COPD character-
istics as determinants of physical activity, such as FEV1 (13
studies), exercise capacity measured by 6-min walk distance or
VO2 peak obtained during an incremental exercise test (7 studies)
and dyspnoea (6 studies).
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Socio-demographic, lifestyle and environmental
determinants
Between two and six studies assessed the role of sex, age, cul-
tural group, marital status, socioeconomic status, education,
working status, smoking status, alcohol consumption and day of
the week as potential determinants of physical activity in
patients with COPD. In most of the studies the design was cross
sectional, thus limiting interpretation of causal direction. In add-
ition, most studies did not adjust observed associations for
potential confounders. Finally, for all of these potential determi-
nants, the results were not consistent across studies. For
example, current smoking status compared with former was
statistically associated with higher physical activity levels in a
given study,S33 while no statistically signiﬁcant differences in
physical activity were found between smoking groups in another
study.S34 Detailed information on estimates of associations, stat-
istically signiﬁcant and non-signiﬁcant, is provided in online
supplementary table S3. Overall, the quality of evidence for sex
and age as determinants of physical activity in patients with
COPD was moderate and very low for the remaining socio-
demographic, lifestyle and environmental factors (table 2A).
Clinical and functional determinants
Regarding clinical and functional determinants, including FEV1,
FVC, hyperinﬂation, gas exchange, exercise capacity, body mass
index (BMI), dyspnoea, systemic inﬂammation, comorbidities,
previous exacerbations, quality of life, self-efﬁcacy or emotional
status, most studies were cross sectional and lacked adjustment
for confounders. Associations of physical activity with hyperin-
ﬂation, gas exchange, exercise capacity, dyspnoea, systemic
inﬂammation, previous exacerbations, quality of life and self-
efﬁcacy were consistent, but were inconsistent for FEV1, FVC,
BMI, comorbidities and emotional status. Overall, almost all
associations were based on evidence graded as very low quality,
except the association with hyperinﬂation which was graded as
low quality (table 2B, details in online supplementary table S3).
Drug and non-drug treatments
A large body of literature exists on the effect of exercise training
on physical activity (21 studies). Although most studies were
clinical trials so that the direction of the association could be
established, some of them did not include a control group or
included a control group without randomised allocation. Some
did not control for confounders in the analysis. Furthermore,
results on the effects of these interventions were inconsistent
and the quality of evidence was low. Other non-pharmacological
interventions identiﬁed in this review include physical activity
advice, long-term oxygen therapy and dietary interventions.
Again, design and analytical limitations preclude conﬁdence on
the results, so the quality of the evidence was rated as low to
very low. Finally, only three studies tested the effect of pharma-
cological treatment (long-acting ß2 agonist and/or oral and
inhaled corticosteroids) on physical activity and combine obser-
vational with experimental designs. The results were inconsist-
ent and have several methodological ﬂaws, so the quality of this
evidence was rated as very low (table 2C, details in online sup-
plementary table S3).
Outcomes
The literature covering the effect of physical activity on out-
comes in COPD was smaller than for the determinants of phys-
ical activity, but the overall quality of evidence was better.
Clinically relevant outcomes such as COPD exacerbations and
mortality were assessed in eight and seven studies, respectively,
which were of longitudinal design (thus showing the outcome
to occur subsequent to a level of physical activity being
Figure 1 Flow diagram of process of systematic literature search. *Details for reason for exclusion in online supplementary table S1.
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Table 1 Reference details, design and number of subjects of 86 studies reporting associations between physical activity and its determinants or outcomes in patients with COPD
Reference Study design n Reference Study design n Reference Study design n
Altenburg WA, 2013S1 Cross sectional 155 Garcia-Aymerich J, 2004S30 Cross sectional 346 Pitta, F. 2009S59 Cross-sectional 80
Beauchamp MK, 2012S2 Cross sectional 37 Garcia-Aymerich J, 2006S31 Cohort 2386 Pomidori, L. 2012S60 Randomised non-controlled parallel study 36
Behnke M, 2005S3 Non-randomised controlled study 88 Garcia-Aymerich J, 2008S32 Cohort 2226 Probst, VS. 2011S61 Randomised non-controlled parallel study 40
Bendstrup KE, 1997S4 Randomised controlled trial 32 Garcia-Aymerich J, 2009S33 Cross sectional 341 Roig, M. 2011S62 Cohort 101
Benzo R, 2010S5 Cohort 597 Garcia-Rio F, 2009S34 Cross sectional 110 Sandland, CJ. 2008S63 Randomised controlled trial 20
Berry M, 2006S6 Cross sectional 291 Garcia-Rio F, 2012S35 Cohort 173 Schou, L. 2013S64 Randomised controlled trial 44
Berry M, 2010S7 Randomised non-controlled
parallel study
176 Goto Y, 2004S36 Non-randomised
controlled study
30 Sewell, L. 2005S65 Randomised non-controlled parallel study 180
Bestall J, 1999S8 Cross sectional 100 Hartman JE, 2013S37 Cross sectional 113 Sewell, L. 2010S66 Non-controlled study 95
Bon J, 2011S9 Cross sectional 190 Hataji O, 2013S38 Non-controlled study 23 Silva, DR. 2011S67 Cross-sectional 95
Bossenbroek L, 2009S10 Case–control 62 Inal-Ince D, 2005S39 Cross sectional 30 Skumlien, S. 2006S68 Cross-sectional 110
Bourbeau J, 2007S11 Cohort 421 Jehn M, 2012S40 Cross sectional 107 Skumlien, S. 2008S69 Non-randomised non-controlled
parallel study
40
Breyer MK, 2010S12 Randomised controlled trial 60 Katajisto M, 2012S41 Cross sectional 719 Takigawa, N. 2007S70 Non-controlled study 225
Chao PW, 2011S13 Cross sectional 21 Lahaije A, 2013S42 Cross sectional 57 Troosters, T. 2010, Respir MedS71 Cross-sectional 70
Chen Y, 2006S14 Cohort 145 Lee H, 2011S43 Cross sectional 131 Tsara, V. 2008S72 Case-control 133
Coronado M, 2003S15 Non-controlled study 15 Lemmens KMM, 2008S44 Cross sectional 278 Van Gestel, AJ. 2012S73 Cross-sectional 154
Dal Negro R, 2010S16 Randomised controlled trial 32 Lore, V, 2006S45 Cross sectional 23 Van Remoortel, H. 2013S74 Cross-sectional 59
Dallas MI, 2009S17 Non-controlled study 45 Mador MJ, 2011S46 Non-controlled study 24 Vergeret, J. 1989S75 Cohort 243
Daly C, 2011S18 Non-controlled study 8 Miravitlles M, 2011S47 Cohort 346 Waatevik, M. 2012S76 Cross-sectional 370
de Blok BM, 2006S19 Randomised controlled trial 21 Monteiro F, 2012S48 Cross sectional 74 Wakabayashi, R. 2011S77 Randomised controlled trial 102
Effing T, 2011S20 Randomised controlled trial 153 Moy M, 2009S49 Cross sectional 17 Wakabayashi, R. 2011S78 Cross-sectional 389
Egan C, 2012S21 Non-controlled study 47 Moy M, 2013S50 Cohort 169 Walker, PP. 2008S79 Non-controlled study 23
Eisner MD, 2008S22 Cross-sectional 1202 Nguyen HQ, 2009S51 Randomised controlled trial 17 Waschki, B. 2011S80 Cohort 169
Eliason G, 2011S23 Cross-sectional 44 Nguyen HQ, 2013S52 Cross-sectional 148 Watz, H. 2008S81 Cross-sectional 170
Esteban C, 2006S24 Cohort 611 Nield M, 2005S53 Non-controlled study 48 Watz, H. 2009S82 Cross-sectional 170
Esteban C, 2010S25 Cohort 391 Okubadejo AA, 1997S54 Case–control 42 Watz, H. 2009S83 Cross-sectional 163
Esteban C, 2011S26 Cohort 611 Palop Cervera M, 2010S55 Case–control 125 Weekes, CE. 2009S84 Randomised controlled trial 59
Faager G, 2004S27 Randomised controlled trial 20 Pitta F, 2006S56 Cohort 17 Wewel, A. 2008S85 Non-controlled study 21
Faulkner J, 2010S28 Randomised controlled trial 20 Pitta F, 2006S57 Cross sectional 23 Yeo, J. 2006S86 Cross-sectional 27
Garcia-Aymerich J, 2003S29 Cohort 340 Pitta F, 2008S58 Cross sectional 40
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Table 2 Quality of evidence for determinants and outcomes of physical activity in COPD, as identified in 86 studies
N studies Direction established Control for confounding Directness Consistency Strength Low precision Other Confidence ratingDeterminant
(A) Quality of evidence for socio-demographic, lifestyle and environmental determinants of physical activity
AgeS30 S33 S34 S57 S71 S81 6 na na Yes −11 No No No +++ (moderate)
Alcohol consumptionS30 S34 2 −22 −14 Yes −11 No −16 No + (very low)
Cultural groupS14 S59 S71 3 −12 na −13 −11 No No No + (very low)
Day of the weekS45 S49 S82 3 −22 −14 Yes −11 No No No + (very low)
EducationS30 S33 S34 3 −22 −14 Yes −11 No No No + (very low)
Marital statusS30 S33 2 −22 −14 Yes −11 No No No + (very low)
SexS30 S33 S34 S57 S68 S81 6 na na Yes −11 No No No +++ (moderate)
Smoking habitS30 S33 S34 3 −22 −14 Yes −11 No −16 No + (very low)
Socioeconomic statusS30 S33 2 −22 −15 Yes −11 No No No + (very low)
Working statusS30 S33 S34 3 −22 −14 Yes −11 No No No + (very low)
(B) Quality of evidence for functional and clinical determinants of physical activity
BODE indexS34 S49 S57 S81 S83 5 −22 −15 Yes −11 No No No + (very low)
Body mass indexS30 S34 S48 S57 S81 5 −22 −15 Yes −11 No No No + (very low)
CardiovascularS30 S81 2 −22 −15 Yes −11 No −16 −17 + (very low)
DyspnoeaS8 S41 S30 S34 S52 S57 S83 7 −22 −15 Yes yes No No No + (very low)
Emotional statusS30 S52 2 −22 Yes Yes −11 No No No + (very low)
Exercise capacity (VO2 max, 6MWD)
S1 S6 S34 S37 S49 S52 S57 S74 S83 9 −22 −15 Yes yes No No No + (very low)
FEV1
S6 S22 S30 S34 S41 S42 S49 S57 S58 S71 S81 S82 S83 S86 14 −12 −15 Yes −11 No No No + (very low)
FVCS34 S57 2 −12 Yes Yes −11 No No −112 + (very low)
Gas exchange (DLco)S34 S74 2 −22 −14 Yes yes No No No + (very low)
Gas exchange (PCO2)
S30 S34 2 −22 −14 Yes yes No No No + (very low)
Gas exchange (PO2)
S30 S34 2 −22 −14 Yes yes No No No + (very low)
HyperinflationS34 S37 S42 S57 S58 5 −22 Yes Yes yes No No No ++ (low)
Osteoarticular conditionS30 S49 2 −22 −14 Yes −11 No −16 No + (very low)
Previous exacerbationS11 S30 S56 3 −12 −14 Yes yes No No −17 + (very low)
Quality of life/health-related quality of lifeS1 S30 S34 S49 S57 5 −22 −14 Yes yes No No No + (very low)
Self-efficacyS1 S37 2 −22 Yes Yes yes No No −17 + (very low)
Systemic inflammationS34 S81 2 −22 −15 Yes yes No No −17 + (very low)
(C) Quality of evidence for interventions to modify levels of physical activity
Dietary interventionS16 S84 2 Yes Yes Yes −11 No No −112 ++ (low)
Exercise trainingS3 S4 S7 S12 S15 S17 S18 S20 S21 S27 S28 S46 S53 S60 S61 S64 S65 S66 S69 S70 S79 21 Yes −18 Yes −11 No No No ++ (low)
Long-acting β2 agonist/corticosteroidsS30 S34 S38 3 −22 −18 Yes −11 No −16 No + (very low)
Long-term oxygen therapyS30 S34 S54 S63 S72 S75 6 Yes Yes Yes −11 No No −110,11 ++ (low)
Physical activity adviceS19 S51 S85 3 Yes −18 Yes −11 No −19 No + (very low)
Outcome
(D) Quality of evidence for outcomes as a result of different levels of physical activity
BalanceS2 S62 2 −12 −18 Yes −11 No No −112,13 + (very low)
Bone mineral densityS9 S67 2 −22 −18 Yes −11 No No −113 + (very low)
DyspnoeaS33 S44 2 −12 Yes Yes Yes No No −113 ++ (low)
ExacerbationsS5 S14 S29 S31 S32 S35 S50 S56 8 Yes Yes Yes Yes No No −113 +++ (moderate)
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deﬁned), controlled for confounders and provided consistent
results. Therefore, quality of evidence was moderate for both
outcomes. Unfortunately, we could not perform any
meta-analysis because of the heterogeneity of the studies but we
illustrated graphically the effect estimate in each study for
exacerbations (ﬁgure 2) and mortality (ﬁgure 3). Associations
for other clinical outcomes such as dyspnoea, health-related
quality of life, exercise capacity and FEV1 were lacking in con-
sistency. Although the underlying studies are often of high
quality, we downgraded the quality of evidence from high to
moderate because of a lack of direct measures of physical activ-
ity. Therefore, quality of evidence is rated as low to very low
(table 2D, details in online supplementary table S4).
Conceptual model for physical activity in patients with
COPD
Using information from table 2, we developed a conceptual
model for physical activity in COPD (ﬁgure 4). In addition to
quality of the evidence, the ﬁgure also provides visual informa-
tion on causal direction and the consistency of associations as
supported by existing literature.
DISCUSSION
The main ﬁndings of this systematic review are, ﬁrst, there are
many studies on clinical, functional, socio-demographic and life-
style factors as determinants of physical activity in patients with
COPD. Unfortunately, the quality of evidence remains very low,
mainly because the causal direction of these associations could
not be established due to the cross-sectional nature of most
studies or because of a lack of control for confounding factors.
Second, only a few interventions have been tested as determi-
nants of physical activity, all with inconsistent results. Third,
there is consistent evidence of effects of physical activity on
COPD exacerbations and mortality.
Signiﬁcance of the ﬁndings
This systematic review provides important information on what
we know today and where research needs to be prioritised.
First, available information today does not clearly answer what
the determinants of physical activity are in patients with COPD.
This is mostly due to the fact that available research has been
cross sectional, which even in the case of consistent results, does
not conclusively establish if a factor needs to be considered a
determinant (exists before levels of physical activity change) or
an outcome (results of different levels of physical activity).
Some may argue that the rich available data on determinants of
exercise capacity (eg, hyperinﬂation, ventilatory response to
exercise, muscle weakness or dyspnoea)13–15 can be extrapolated
as determinants of physical activity. However, it is well known
that physical activity (a complex behaviour) and capacity or
physical ﬁtness (a set of attributes) are correlated only to a mod-
erate extent10 and constitute different concepts. This is sup-
ported by the fact that some determinants of exercise capacity
are not associated with physical activity.
Second, evidence for the effect of therapeutic interventions
on physical activity levels is of low to very low quality and is
inconsistent. The most studied intervention is exercise training,
with 21 studies assessing the effects of exercise training on phys-
ical activity in patients with COPD. However, some limitations
lowered the conﬁdence in the estimates of effect, such as the
lack of a control group in half of the studies or the inconsistency
of results (eg, half of studies found signiﬁcant associations and
half did not). In addition, it is important to point out that we
included all these interventions that offered at least exercise
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training but we did not consider the type of exercise, the dur-
ation of the intervention programme or the training intensity
used, which varied signiﬁcantly across studies. Surprisingly,
there is scarce evidence about the effects of commonly used
pharmacological agents, such as long-acting ß2 agonists, on
physical activity levels. This should attract attention of the
industry since some drug treatments could theoretically increase
levels of physical activity, for example, as a result of decreased
hyperinﬂation, reduced symptoms and enhanced exercise
endurance.
Third, we identiﬁed that the best available evidence is for the
association of physical activity with mortality and COPD exacer-
bations. These results are based on longitudinal studies, the
results are consistent, and all estimates of associations were
adjusted for known confounders, such as age, sex, BMI, severity
and previous exacerbations. Nevertheless, the quality of the evi-
dence is still moderate since physical activity was assessed using
questionnaires instead of more precise tools, such as activity
monitors in the largest studies. Finally, we could not establish
some clinically important parameters such as FEV1, dyspnoea
and exercise capacity as clear outcomes of physical activity
because of the lack of consistent results across studies, small
sample sizes leading to imprecise estimates and cross-sectional
study design (not allowing directionality). Indeed, diverse cross-
sectional studies approached the associations between physical
activity and the above-mentioned parameters, some under the
hypothesis they would be determinants of physical activity,
while other authors hypothesised they would be outcomes of
physical activity. Several studies in the general population
support bi-directionality for these associations.16 17
Critique of the method
A strength of this review is the rigorous systematic review meth-
odology followed which was key to dealing effectively with a
very heterogeneous literature. Additionally, we report signiﬁcant
and non-signiﬁcant associations, which allows a comprehensive
evaluation of the consistency and strength of the associations
described. A challenge of this review was to identify whether a
speciﬁc association should be categorised as ‘determinant’,
‘outcome’ or be excluded. In most cross-sectional studies the
authors did not clearly state the hypotheses about the direction-
ality of associations. Our selection of some (but not all) cross-
sectional studies and non-directional measures of association
(such as correlation coefﬁcients) was restricted to those where
the authors clearly described the hypothesis about directionality
in the introduction or methods section.
Future research direction
The results of the present review should be taken into account
for further research. Speciﬁcally, physical activity should be
included as an outcome in randomised controlled trials to
provide knowledge on the potential effects of drug and
Figure 3 Graphical illustration of the individual study effects of physical activity on reduced risk of mortality.
Figure 2 Graphical illustration of the
individual study effects of physical
activity on reduced risk of
exacerbations. Pitta 2006 was
excluded from the graph because it did
not provide a risk ratio.
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non-drug treatments on this relevant outcome. Also, this review
supports the need, prior to start any study, of a careful review of
the existing literature in order not to miss (in data collection or
statistical analyses) relevant potential confounders. We acknow-
ledge that cross-sectional studies are easier to perform than lon-
gitudinal studies but the quality assessment here shows that they
can just yield low-quality evidence about the association of
determinants and outcomes of physical activity. The research
community should make an effort to conduct prospectively
planned cohort studies and randomised trials to provide a stron-
ger evidence base for determinants and outcomes of physical
activity and for developing recommendations for or against
treatments in clinical guidelines.
In conclusion, the consistent effects of physical activity on
mortality and COPD exacerbation are in contrast to the poor
evidence about determinants of physical activity, including
current COPD treatments and other outcomes of physical activ-
ity. There is a need for high-quality observational studies and
randomised trials that use valid and accurate measurements of
physical activity.
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Figure 4 Conceptual model of
physical activity in patients with COPD.
Grading was done separately for each
individual determinant/outcome
(table 2). Variables of the same
category sharing the same conﬁdence
rating are grouped together in this
ﬁgure for clarity. Socio-demographic,
lifestyle and environment, and some
clinical variables (FEV1, body mass
index, emotional status and
comorbidities) do not show consistent
effects on physical activity. The
association between other clinical and
functional determinants and physical
activity such as hyperinﬂation, exercise
capacity, dyspnoea, previous
exacerbations, gas exchange, systemic
inﬂammation, quality of life and
self-efﬁcacy is consistent across
studies, but lacking directionality
because mostly it is based on
cross-sectional studies. Studies on
pharmacological and
non-pharmacological treatments as
determinants of physical activity are all
longitudinal and thus, by design,
provided a basis for a clear direction of
the associations. But the results are
inconsistent with some treatments
showing an increase in physical activity
and some showing no effect.
Regarding the outcomes, only COPD
exacerbation and mortality show
consistent effects with clear
directionality and based on moderate
quality evidence.
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